dc.contributor.author |
Singh, A K |
|
dc.contributor.author |
Yadav, A B |
|
dc.contributor.author |
Garg, Rajiv |
|
dc.contributor.author |
Misra, Amit |
|
dc.date.accessioned |
2014-07-31T10:01:28Z |
|
dc.date.available |
2014-07-31T10:01:28Z |
|
dc.date.issued |
2014 |
|
dc.identifier.citation |
Pharmacogenomics, 2014,15(4), 497-508 |
en |
dc.identifier.uri |
http://hdl.handle.net/123456789/1324 |
|
dc.description.abstract |
Aims: To investigate survival of Mycobacterium tuberculosis in primary macrophages with single nucleotide polymorphisms (SNPs) affecting cytokine secretion, under treatment with drugs in solution or microparticles.
Materials & Methods: Volunteers were typed for tumor necrosis factor (TNF) (-308 G/A), interleukin (IL)-10 (-1082 A/G) and IL-4 (-590 C/T). Monocyte-derived macrophages (MDMs) were infected in vitro. Cytokine secretion and survival of intracellular bacilli were estimated.
Results: IL-10 AG associated with high secretion in uninfected and infected MDMs (P<0.05) and was reduced more effectively by microparticles than drugs, irrespective of genotype (P<0.05). Differences were observed between IL-4 secretion by CC and TT (P<0.1). Bacteria proliferated more in MDMs from volunteers with higher IL-4 (P<0.05). Microparticles showed higher efficacy (P<0.05) than drugs.
Conclusions: IL-4 and IL-10 SNPs affect the ability of macrophages to counter infection with M tuberculosis. Microparticles elicit favourable macrophage cytokines regardless of SNPs. |
en |
dc.format.extent |
251062 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.language.iso |
en |
en |
dc.relation.ispartofseries |
CSIR-CDRI Communication No.8573 |
en |
dc.subject |
SNPs |
en |
dc.subject |
Inhalable Microparticles |
en |
dc.subject |
Isoniazid, Rifabutin |
en |
dc.subject |
Tumor Necrosis Factor |
en |
dc.subject |
Interleukin 10 |
en |
dc.subject |
Interleukin 4 |
en |
dc.title |
Single-nucleotide polymorphic macrophage cytokine regulation by Mycobacterium tuberculosis and drug treatment |
en |
dc.type |
Article |
en |